Delivery Order SPE2DB24D2216-SPE2DB25FGPRU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $77,327.57 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count packaging) on July 28, 2025. This competitively awarded, firm fixed-price delivery order, which is not subject to any set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units) with a ceiling value of $20,252.06. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Gilenya 0.5 mg capsules in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, valued at $25,513.12 and scheduled for completion by August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,918 to Amerisourcebergen Drug Corporation for 30 capsules of the pharmaceutical Gilenya 0.5 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is July 11-12, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order to supply the requested...
- The Defense Logistics Agency awarded a $2,989.64 firm fixed price delivery order to Amerisourcebergen Drug Corp for 30 capsules of the 0.5 mg dosage of Gilenya to treat multiple sclerosis. Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 3, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corp, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor and services...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,597.07, is for the supply of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $4,559.32 to supply 30 capsules of the 0.5 mg dosage of Gilenya. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. Issued against an indefinite-delivery contract with no set-aside designation, this award continues Amerisourcebergen's support of DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,054.04, is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a firm fixed price and is set to expire on May 14, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gilenya 0.5 mg capsules. The contract has a firm fixed price of $19,725.81 and an ultimate completion date of November 22, 2021. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the parent company, Cencora, Inc. (doing business as AmerisourceBergen),...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPRUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gilenya 0.5 mg capsules (30-count) valued at $11,008.02 under a firm fixed price arrangement. The contract, which is not set-aside, is scheduled for completion by August 29, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical medical procurement needs for federal military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company has demonstrated capability to meet federal procurement requirements through competitive award processes, supplying diverse pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Gilenya, a neurological treatment medication, aligns with the company's established distribution of specialty pharmaceuticals supporting military health service operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 8/28/25 |